ClinicalTrials.gg
Drug

Pozelimab clinical trials

Also written REGN3918.

studies test it
14
open now
4
in phase 3
5
first study started
2017

How each study uses pozelimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the pozelimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Aug 2023 · VEOPOZ · BLA 761339 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pozelimab
11

Brand

VEOPOZ
1

Development codes

REGN3918
12

Studies by the year they started

14 studies that test it; most in 2021 (4)

Studies that test pozelimab, by start year
YearStudies
20171
20192
20203
20214
20231
20263

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
4
Phase 3
5
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 0

Regeneron Pharmaceuticals (14)

Often tested with

Tested in the same studies.

Cemdisiran (6)

Studies

Open first, then newest update. How each study uses pozelimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Given beside what is tested · 4 — pozelimab is usual care or a partner of the new treatment

Codes

What other systems call pozelimab · ClinicalTrials.gg INT002137

  • MeSH (NLM) C000731768pozelimabOne source NLM
  • UNII (FDA) 0JJ21K6L2IPOZELIMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q121708361pozelimabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166423PozelimabOne source FDA
  • DrugBank DB15218One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.